|
PIK3CB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.232480E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.228280E-02 |
| Normal-vs-Stage2 |
6.595800E-02 |
| Normal-vs-Stage3 |
8.26650000000928E-05 |
| Normal-vs-Stage4 |
1.839730E-03 |
| Stage1-vs-Stage2 |
4.810800E-01 |
| Stage1-vs-Stage3 |
3.428400E-02 |
| Stage1-vs-Stage4 |
1.154770E-01 |
| Stage2-vs-Stage3 |
6.746400E-01 |
| Stage2-vs-Stage4 |
7.978000E-01 |
| Stage3-vs-Stage4 |
8.302000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.815600E-04 |
| Normal-vs-AfricanAmerican |
5.439500E-04 |
| Normal-vs-Asian |
1.453230E-01 |
| Caucasian-vs-AfricanAmerican |
2.144200E-01 |
| Caucasian-vs-Asian |
9.675000E-01 |
| AfricanAmerican-vs-Asian |
6.618200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.960870E-04 |
| Normal-vs-Female |
3.035500E-03 |
| Male-vs-Female |
6.000200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.247540E-02 |
| Normal-vs-Age(41-60Yrs) |
1.350150E-02 |
| Normal-vs-Age(61-80Yrs) |
2.994500E-04 |
| Normal-vs-Age(81-100Yrs) |
4.06299999977655E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.102200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.245000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.014600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.779600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.741200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.453900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.839400E-01 |
| Normal-vs-Grade 2 |
6.734300E-02 |
| Normal-vs-Grade 3 |
8.605500E-04 |
| Normal-vs-Grade 4 |
3.06250025339239E-10 |
| Grade 1-vs-Grade 2 |
9.841500E-02 |
| Grade 1-vs-Grade 3 |
7.098000E-02 |
| Grade 1-vs-Grade 4 |
8.32139999999981E-05 |
| Grade 2-vs-Grade 3 |
1.482610E-01 |
| Grade 2-vs-Grade 4 |
9.63179999979857E-07 |
| Grade 3-vs-Grade 4 |
2.619500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.069000E-01 |
| Normal-vs-ccB subtype |
1.90219999995911E-06 |
| ccA subtype-vs-ccB subtype |
8.21330000000398E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.379570E-03 |
| Normal-vs-N1 |
6.896400E-01 |
| N0-vs-N1 |
5.413400E-01 |
|
|
